Business

Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial

Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial

articleImugene LtdJanuary 20, 20215/company/imugene-ltd/news/imugene-dose-escalates-in-pd1-vaxx-phase-1-clinical-trial
Imugene Dose Escalates in PD1-VAXX Phase 1 Clinical Trial

About this update from Imugene Ltd

[{"type":"text","content":"Imugene Ltd has released a press release. View Attachment","length":216,"tagName":"div"}]

More updates from Imugene Ltd